First, we suggest that improved NAD status could help blunt the severity of infection by sustaining PARP-dependent IFN signaling in the face of the self-limiting nature of cellular NAD during infection and by limiting the storm of inflammatory cytokines that is typically associated with serious disease (43). The gene discussed is IFNA1; the disease is infection.